Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
6 studies found for:    Creutzfeldt-Jakob Disease

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Completed
Has Results 		CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Condition: Creutzfeldt-Jakob Disease
Interventions: Drug: Quinacrine;   Drug: Placebo
2 Unknown † Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
3 Completed The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Condition: Hemoglobinuria, Paroxysmal
Intervention:
4 Unknown † PRION-1: Quinacrine for Human Prion Disease
Condition: Prion Disease
Intervention: Drug: Quinacrine
5 Recruiting Fibrinogen as an Alternative to FFP in Aortic Surgery.
Condition: Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair
Interventions: Biological: Fibrinogen concentrate;   Biological: Fresh Frozen Plasma
6 Completed
Has Results 		A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD
Condition: Comparison of Octaplas LG and Octaplas SD
Interventions: Biological: Octaplas LG;   Biological: Octaplas SD
To Top

† Indicates status has not been verified in more than two years